Clinical Trial

Longitudinal Multi-Modality Imaging in Progressive Apraxia of Speech

Recruiting Phase 4
View on ClinicalTrials.gov →
Summary
The study is designed to determine the relationship between structural and functional changes in the brain on imaging and progression of speech and language, neurological and neuropsychological features in patients with neurodegenerative apraxia of speech (AOS).
Protocol Amendment History 16 amendments
This ClinicalTrials.gov record has been amended 16 times since 2013-03-21; most recent amendment 2025-11-10.
Status change: Completed → Recruiting 2018-06-25
Status change: Recruiting → Completed 2018-06-05
Status change: Enrolling by Invitation → Recruiting 2015-09-03
Trial Details
NCT Number NCT01818661
Lead Sponsor Mayo Clinic
Collaborators: National Institute on Deafness and Other Communication Disorders (NIDCD)
Conditions PPA, Non-fluent Aphasia, Apraxia of Speech, Primary Progressive Non-fluent Aphasia, Primary Progressive Aphasia
Enrollment 50 participants
Start Date 2018-07-01
Primary Completion 2028-06 (estimated)
Study Completion 2028-06 (estimated)
Updated on ClinicalTrials.gov 2025-11-12